Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

In vivo Compound Profiling, Xenogen Biosciences
June 2005
SHARING OPTIONS:

Xenogen Biosciences offers a new in vivo comprehensive compound profiling program for preclinical research. Xenogen's Comprehensive Com-pound Profiling Program is a customized battery of pharmacological tests to (i) assess the therapeutic efficacy of (optimized) lead compounds and/or drug development candidates by analyzing their effects on key physiological functions in animals, (ii) screen for potential side effects caused by the administration of such compounds, and/or (iii) discover disease indications for such compounds that were not previously known, helping expand the market potential of those drug candidates.
 
Xenogen Biosciences
877.936.6436

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.